Topoisomerase I peptide-loaded dendritic cells induce autoantibody response as well as skin and lung fibrosis

References

• Passaleva, A., G. Massai, M. Matucci-Cerinic, et al 2009. Immunological abnormalities in a group of patients with limited cutaneous systemic sclerosis and prominent vascular disease. Autoimmunity. 6: 283–291
   Web of Science ®Google Scholar
• Katsumoto, T. R., M. L. Whitfield, and M. K. Connolly. 2011. The pathogenesis of systemic sclerosis. Annu. Rev. Pathol. 6: 509–537
   PubMed Web of Science ®Google Scholar
• Varga, J., and D. Abraham. 2007. Systemic sclerosis: a prototypic multisystem fibrotic disorder. J. Clin. Investig. 117: 557–567
   PubMed Web of Science ®Google Scholar
• Dumoitier, N., S. Lofek, and L. Mouthon. 2014. Pathophysiology of systemic sclerosis: state of the art in 2014. Presse. Med. 43: e267–e278
   Google Scholar
• van Bon, L., M. Cossu, and T. R. Radstake. 2011. An update on an immune system that goes awry in systemic sclerosis. Curr. Opin. Rheumatol. 23: 505–510
   PubMed Web of Science ®Google Scholar
• Wick, G., C. Grundtman, C. Mayerl, et al 2013. The immunology of fibrosis. Annu. Rev. Immunol. 31: 107–135
   PubMed Web of Science ®Google Scholar
• Pattanaik, D., M. Brown, B. C. Postlethwaite, and A. E. Postlethwaite. 2015. Pathogenesis of systemic sclerosis. Front. Immunol. 6: 272
   PubMed Web of Science ®Google Scholar
• Koenig, M., F. Joyal, M. J. Fritzler, et al 2008. Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis. Arthritis Rheum. 58: 3902–3912
   Google Scholar
• Domsic, R. T. 2014. Scleroderma: the role of serum autoantibodies. In Defining Specific Clinical Phenotypes and Organ System Involvement. Curr. Opin. Rheumatol. 26: 646–652
   PubMed Web of Science ®Google Scholar
• Fava, A., R. Cimbro, F. M. Wigley, et al 2016. Frequency of circulating topoisomerase-I-specific CD4 T cells predicts presence and progression of interstitial lung disease in scleroderma. Arthritis Res. Ther. 18: 99
   PubMed Web of Science ®Google Scholar
• Bhattacharyya, S., J. Wei, and J. Varga. 2012. Understanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities. Nat. Rev. Rheumatol. 8: 42–54
   Web of Science ®Google Scholar
• Kahari, V. M., M. Sandberg, H. Kalimo, et al 1988. Identification of fibroblasts responsible for increased collagen production in localized scleroderma by in situ hybridization. J. Investig. Dermatol. 90: 664–670
   PubMed Web of Science ®Google Scholar
• Hugle, T., K. White, and J. M. van Laar. 2012. Cell-to-cell contact of activated mast cells with fibroblasts and lymphocytes in systemic sclerosis. Ann. Rheum. Dis. 71: 1582
   PubMed Web of Science ®Google Scholar
• Lu, T. T. 2011. Dendritic cells: novel players in fibrosis and scleroderma. Curr. Rheumatol. Rep. 14: 30–38
   Web of Science ®Google Scholar
• Marchal-Somme, J., Y. Uzunhan, S. Marchand-Adam, et al 2006. Cutting edge: nonproliferating mature immune cells form a novel type of organized lymphoid structure in idiopathic pulmonary fibrosis. J. Immunol. 176: 5735–5739
   PubMed Web of Science ®Google Scholar
• Bantsimba-Malanda, C., J. Marchal-Somme, D. Goven, et al 2010. A role for dendritic cells in bleomycin-induced pulmonary fibrosis in mice?. Am. J. Respir. Crit. Care Med. 182: 385–395
   PubMed Web of Science ®Google Scholar
• Chung, M. P., M. M. Monick, N. Y. Hamzeh, et al 2003. Role of repeated lung injury and genetic background in bleomycin-induced fibrosis. Am. J. Respir. Cell Mol. Biol. 29: 375–380
   PubMed Web of Science ®Google Scholar
• Degryse, A. L., and W. E. Lawson. 2011. Progress toward improving animal models for idiopathic pulmonary fibrosis. Am. J. Med. Sci. 341: 444–449
   PubMed Web of Science ®Google Scholar
• Lee, R., C. Reese, M. Bonner, et al 2014. Bleomycin delivery by osmotic minipump: similarity to human scleroderma interstitial lung disease. Am J. Physiol. Lung Cell. Mol. Physiol. 306: L736–L748
   Google Scholar
• Servettaz, A., C. Goulvestre, N. Kavian, et al 2009. Selective oxidation of DNA topoisomerase 1 induces systemic sclerosis in the mouse. J. Immunol. 182: 5855–5864
   PubMed Web of Science ®Google Scholar
• Beyer, C., G. Schett, O. Distler, and J. H. Distler. 2010. Animal models of systemic sclerosis: prospects and limitations. Arthritis Rheum. 62: 2831–2844
   PubMed Web of Science ®Google Scholar
• Szapiel, S. V., J. D. Fulmer, G. W. Hunninghake, et al 1981. Hereditary emphysema in the tight-skin (Tsk/+) mouse. Am. Rev. Respir. Dis. 123: 680–685
   PubMed Web of Science ®Google Scholar
• Manetti, M., I. Rosa, A. F. Milia, et al 2014. Inactivation of urokinase-type plasminogen activator receptor (uPAR) gene induces dermal and pulmonary fibrosis and peripheral microvasculopathy in mice: a new model of experimental scleroderma? Ann. Rheum. Dis. 73: 1700–1709
   PubMed Web of Science ®Google Scholar
• Yoshizaki, A., K. Yanaba, A. Ogawa, et al 2011. Immunization with DNA topoisomerase I and Freund's complete adjuvant induces skin and lung fibrosis and autoimmunity via interleukin-6 signaling. Arthritis Rheum. 63: 3575–3585
   PubMed Web of Science ®Google Scholar
• Hu, P. Q., A. A. Hurwitz, and J. J. Oppenheim. 2007. Immunization with DNA topoisomerase I induces autoimmune responses but not scleroderma-like pathologies in mice. J. Rheumatol. 34: 2243–2252
   PubMed Web of Science ®Google Scholar
• Weir, C. R., K. Nicolson, and B. T. Backstrom. 2002. Experimental autoimmune encephalomyelitis induction in naive mice by dendritic cells presenting a self-peptide. Immunol. Cell Biol. 80: 14–20
   PubMed Web of Science ®Google Scholar
• Eriksson, U., R. Ricci, L. Hunziker, et al 2003. Dendritic cell-induced autoimmune heart failure requires cooperation between adaptive and innate immunity. Nat. Med. 9: 1484–1490
   PubMed Web of Science ®Google Scholar
• Fortin, G., M. Raymond, V. Q. Van, et al 2009. A role for CD47 in the development of experimental colitis mediated by SIRPalpha + CD103- dendritic cells. J. Exp. Med. 206: 1995–2011
   PubMed Web of Science ®Google Scholar
• Tang, H., W. Cao, S. P. Kasturi, et al 2010. The T helper type 2 response to cysteine proteases requires dendritic cell–basophil cooperation via ROS-mediated signaling. Nat. Immunol. 11: 608–617
   PubMed Web of Science ®Google Scholar
• Raymond, M., V. Q. Van, K. Wakahara, et al 2011. Lung dendritic cells induce T(H)17 cells that produce T(H)2 cytokines, express GATA-3, and promote airway inflammation. J. Allergy Clin. Immunol. 128: 192201.e196
   Google Scholar
• Veeraraghavan, S., E. A. Renzoni, H. Jeal, et al 2004. Mapping of the immunodominant T cell epitopes of the protein topoisomerase I. Ann. Rheum. Dis. 63: 982–987
   PubMed Web of Science ®Google Scholar
• Oriss, T. B., P. Q. Hu, and T. M. Wright. 2001. Distinct autoreactive T cell responses to native and fragmented DNA topoisomerase I: influence of APC type and IL-2. J. Immunol. 166: 5456–5463
   PubMed Web of Science ®Google Scholar
• Simon, D., T. Czompoly, T. Berki, et al 2009. Naturally occurring and disease-associated auto-antibodies against topoisomerase I: a fine epitope mapping study in systemic sclerosis and systemic lupus erythematosus. Int. Immunol. 21: 415–422
   PubMed Web of Science ®Google Scholar
• Muryoi, T., K. N. Kasturi, M. J. Kafina, et al 1992. Antitopoisomerase I monoclonal autoantibodies from scleroderma patients and tight skin mouse interact with similar epitopes. J. Exp. Med. 175: 1103–1109
   PubMed Web of Science ®Google Scholar
• Koiwai, O., Y. Yasui, Y. Sakai, et al 1993. Cloning of the mouse cDNA encoding DNA topoisomerase I and chromosomal location of the gene. Gene 125: 211–216
   PubMed Web of Science ®Google Scholar
• van Rijt, L. S., N. Vos, M. Willart, et al 2011. Persistent activation of dendritic cells after resolution of allergic airway inflammation breaks tolerance to inhaled allergens in mice. Am. J. Respir. Crit. Care Med. 184: 303–311
   PubMed Web of Science ®Google Scholar
• Sato, S., M. Fujimoto, M. Hasegawa, and K. Takehara. 2004. Altered blood B lymphocyte homeostasis in systemic sclerosis: expanded naive B cells and diminished but activated memory B cells. Arthritis Rheum. 50: 1918–1927
   Google Scholar
• Georgiev, M., L. M. Agle, J. L. Chu, et al 2005. Mature dendritic cells readily break tolerance in normal mice but do not lead to disease expression. Arthritis Rheum. 52: 225–238
   PubMed Web of Science ®Google Scholar
• Lakos, G., S. Takagawa, and J. Varga. 2004. Animal Models of Scleroderma. Humana Press Inc., Totowa, NJ
   Google Scholar
• Desmouliere, A., A. Geinoz, F. Gabbiani, and G. Gabbiani. 1993. Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J. Cell Biol. 122: 103–111
   PubMed Web of Science ®Google Scholar
• Bhattacharyya, S., K. Kelley, D. S. Melichian, et al 2013. Toll-like receptor 4 signaling augments transforming growth factor-beta responses: a novel mechanism for maintaining and amplifying fibrosis in scleroderma. Am. J. Pathol. 182: 192–205
   PubMed Web of Science ®Google Scholar
• van Bon, L., A. J. Affandi, J. Broen, et al 2014. Proteome-wide analysis and CXCL4 as a biomarker in systemic sclerosis. N. Engl. J. Med. 370: 433–443
   PubMed Web of Science ®Google Scholar
• Gabrielli, A., E. V. Avvedimento, and T. Krieg. 2009. Scleroderma. N. Engl. J. Med. 360: 1989–2003
   PubMed Web of Science ®Google Scholar
• Henault, J., G. Robitaille, J. L. Senecal, and Y. Raymond. 2006. DNA topoisomerase I binding to fibroblasts induces monocyte adhesion and activation in the presence of anti-topoisomerase I autoantibodies from systemic sclerosis patients. Arthritis Rheum. 54: 963–973
   PubMed Web of Science ®Google Scholar
• Girstun, A., B. Kowalska-Loth, A. Czubaty, et al 2008. Fragment responsible for translocation in the N-terminal domain of human topoisomerase I. Biochem. Biophys. Res. Commun. 366: 250–257
   PubMed Web of Science ®Google Scholar
• Chen, M., A. Dittmann, A. Kuhn, et al 2005. Recruitment of topoisomerase I (Scl-70) to nucleoplasmic proteasomes in response to xenobiotics suggests a role for altered antigen processing in scleroderma. Arthritis Rheum. 52: 877–884
   PubMed Web of Science ®Google Scholar
• Kowal-Bielecka, O., K. Kowal, A. Lewszuk, et al 2005. Beta thromboglobulin and platelet factor 4 in bronchoalveolar lavage fluid of patients with systemic sclerosis. Ann. Rheum. Dis. 64: 484–486
   PubMed Web of Science ®Google Scholar
• McCormick, L. L., Y. Zhang, E. Tootell, and A. C. Gilliam. 1999. Anti-TGF-beta treatment prevents skin and lung fibrosis in murine sclerodermatous graft-versus-host disease: a model for human scleroderma. J. Immunol. 163: 5693–5699
   PubMed Web of Science ®Google Scholar
• Phan, S. H., and S. L. Kunkel. 1992. Lung cytokine production in bleomycin-induced pulmonary fibrosis. Exp. Lung Res. 18: 29–43
   PubMed Web of Science ®Google Scholar
• Eferl, R., P. Hasselblatt, M. Rath, et al 2008. Development of pulmonary fibrosis through a pathway involving the transcription factor Fra-2/AP-1. Proc. Natl. Acad. Sci. U. S. A. 105: 10525–10530
   PubMed Web of Science ®Google Scholar
• Rice, L. M., C. M. Padilla, S. R. McLaughlin, et al 2015. Fresolimumab treatment decreases biomarkers and improves clinical symptoms in systemic sclerosis patients. J. Clin. Investig. 125: 2795–2807
   PubMed Web of Science ®Google Scholar
• Sargent, J. L., A. Milano, S. Bhattacharyya, et al 2010. A TGFbeta-responsive gene signature is associated with a subset of diffuse scleroderma with increased disease severity. J. Investig. Dermatol. 130: 694–705
   PubMed Web of Science ®Google Scholar
• Valentini, G., A. Baroni, K. Esposito, et al 2001. Peripheral blood T lymphocytes from systemic sclerosis patients show both Th1 and Th2 activation. J. Clin. Immunol. 21: 210–217
   PubMed Web of Science ®Google Scholar
• Yang, X., J. Yang, X. Xing, et al 2014. Increased frequency of Th17 cells in systemic sclerosis is related to disease activity and collagen overproduction. Arthritis Res. Ther. 16: R4
   PubMed Web of Science ®Google Scholar
• Brembilla, N. C., and C. Chizzolini. 2012. T cell abnormalities in systemic sclerosis with a focus on Th17 cells. Eur. Cytokine Network 23: 128–139
   PubMed Web of Science ®Google Scholar
• Shi, G., D. J. Field, K. A. Ko, et al 2014. Platelet factor 4 limits Th17 differentiation and cardiac allograft rejection. J. Clin. Investig. 124: 543–552
   PubMed Web of Science ®Google Scholar
• Kool, M., T. Soullie, M. van Nimwegen, et al 2008. Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells. J. Exp. Med. 205: 869–882
   PubMed Web of Science ®Google Scholar
• Del Galdo, F., and M. Matucci-Cerinic. 2014. The search for the perfect animal model discloses the importance of biological targets for the treatment of systemic sclerosis (editorial). Ann. Rheum. Dis. 73: 635–636
   PubMed Web of Science ®Google Scholar